Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT2, also known as Melatonin receptor type 1B or MTNR1B, is one of two high-affinity G protein-coupled receptors (GPCRs) for melatonin. It plays a central role in phase-shifting the internal circadian clock, selectively increases non–rapid eye movement (NREM) sleep, influences light-dependent retinal functions, and regulates bone metabolism. Dysfunction or altered expression/activity of MT2 has been linked with sleep disorders, circadian rhythm abnormalities, mood disorders, pain modulation, and type 2 diabetes pathogenesis.
Gi-mediated inhibition of cAMP/cGMP; PKC activation
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Melatonin Receptor Type 1B (MT2).